European Archives - Page 229 of 1002 - European Medical Journal

BIMZELX®▼ (bimekizumab) Mode of Action

Learn about the mechanism of action for Bimzelx (bimekizumab). To find out more, please visit www.bimzelx.eu…

The Diverse Applications of Radiology

Refky Nicola joins Jonathan to discuss various uses of radiology and what the future holds for the discipline as technology continues to develop.

ROCKETing Forward: The Future of Atopic Dermatitis Treatment Targeting the OX40 Signalling Pathway

View our latest infographic, which spotlights the challenges and opportunities for the treatment of atopic dermatitis (AD), highlighting…

Complex High-risk Interventional Patients and Procedures: Case-based review and patient management.

We are pleased to bring you a roundtable discussion webinar exploring complex high-risk interventional procedures, including comprehensive discussion on a patient case and effective patient management strategies.

Vitiligo Is an Immune Mediated Disease – Do We Have the Right Approach and Tools to Manage?

This two-part podcast series delves into vitiligo as a systemic disease, its known risk factors, and the stigma often associated with the condition.

Interview: Maureen Kohi

Maureen Kohi – University of North Carolina (UNC) at Chapel Hill, USA. During medical school, I found myself gravitating towards…

Children with Atopic Dermatitis More Likely to Develop Other Skin Conditions

Children with atopic dermatitis are more likely to develop other skin conditions. Despite this, researchers reported that many children with AD are not referred for patch testing, and ACD is often underdiagnosed.

A patient's right to thrive, not just survive

Listen to Isabel chatting with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb.

ESMO 2023 Industry Sponsored Satellite Symposium: Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment with Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors

At the 2023 European Society for Medical Oncology (ESMO) Annual Congress, held in Madrid, Spain, Jürgen Wolf, University Hospital Cologne…

VPAG: the UK's ticket to pharma superpower status?

A deal ends months of wrangling between the UK government and the ABPI, but what will it mean for the industry and the UK’s bid to become a life sciences superpower?